Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Basolateral Nuclear Complex | 13 | 2022 | 28 | 7.500 |
Why?
|
| Amygdala | 23 | 2021 | 159 | 6.620 |
Why?
|
| Interneurons | 17 | 2020 | 70 | 4.800 |
Why?
|
| Pyramidal Cells | 14 | 2022 | 79 | 3.640 |
Why?
|
| Neurons | 11 | 2021 | 881 | 2.880 |
Why?
|
| Parvalbumins | 13 | 2020 | 29 | 2.810 |
Why?
|
| Receptor, Muscarinic M1 | 5 | 2022 | 17 | 2.410 |
Why?
|
| Presynaptic Terminals | 12 | 2020 | 34 | 2.320 |
Why?
|
| Dendrites | 13 | 2022 | 44 | 2.310 |
Why?
|
| Synapses | 8 | 2017 | 222 | 1.890 |
Why?
|
| Axons | 5 | 2020 | 139 | 1.850 |
Why?
|
| Cholecystokinin | 4 | 2020 | 29 | 1.700 |
Why?
|
| Intermediate Filaments | 2 | 2021 | 6 | 1.580 |
Why?
|
| Rats, Sprague-Dawley | 24 | 2021 | 2083 | 1.440 |
Why?
|
| Animals | 39 | 2022 | 20881 | 1.160 |
Why?
|
| Receptor, Muscarinic M2 | 2 | 2017 | 8 | 1.130 |
Why?
|
| Rats | 25 | 2021 | 5300 | 1.100 |
Why?
|
| Immunohistochemistry | 15 | 2021 | 1174 | 1.020 |
Why?
|
| Calbindins | 5 | 2020 | 23 | 0.960 |
Why?
|
| Neural Pathways | 4 | 2016 | 324 | 0.840 |
Why?
|
| Acetylcholine | 3 | 2022 | 64 | 0.790 |
Why?
|
| Enkephalins | 3 | 2016 | 89 | 0.750 |
Why?
|
| Macaca mulatta | 4 | 2021 | 77 | 0.720 |
Why?
|
| S100 Calcium Binding Protein G | 6 | 2020 | 21 | 0.720 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2020 | 68 | 0.710 |
Why?
|
| Papio | 1 | 2019 | 27 | 0.700 |
Why?
|
| Macaca fascicularis | 1 | 2019 | 31 | 0.700 |
Why?
|
| Male | 32 | 2022 | 37321 | 0.690 |
Why?
|
| Vesicular Glutamate Transport Protein 1 | 1 | 2019 | 3 | 0.680 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2019 | 4 | 0.680 |
Why?
|
| GABAergic Neurons | 1 | 2019 | 17 | 0.680 |
Why?
|
| Staining and Labeling | 1 | 2019 | 144 | 0.680 |
Why?
|
| Glucuronates | 1 | 2017 | 19 | 0.600 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 4 | 2007 | 107 | 0.590 |
Why?
|
| gamma-Aminobutyric Acid | 6 | 2007 | 208 | 0.580 |
Why?
|
| Dopamine | 2 | 2010 | 474 | 0.560 |
Why?
|
| Somatostatin | 3 | 2007 | 36 | 0.550 |
Why?
|
| Vesicular Acetylcholine Transport Proteins | 2 | 2013 | 5 | 0.540 |
Why?
|
| Cholinergic Neurons | 1 | 2016 | 5 | 0.540 |
Why?
|
| Norepinephrine Plasma Membrane Transport Proteins | 1 | 2016 | 21 | 0.540 |
Why?
|
| Learning | 2 | 2016 | 186 | 0.520 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 511 | 0.490 |
Why?
|
| Dendritic Spines | 5 | 2019 | 76 | 0.490 |
Why?
|
| Microscopy, Immunoelectron | 5 | 2016 | 27 | 0.480 |
Why?
|
| Vasoactive Intestinal Peptide | 5 | 2007 | 19 | 0.480 |
Why?
|
| Hippocampus | 2 | 2017 | 471 | 0.450 |
Why?
|
| Cerebral Cortex | 2 | 2010 | 415 | 0.330 |
Why?
|
| Immunoenzyme Techniques | 5 | 2010 | 196 | 0.310 |
Why?
|
| Calbindin 2 | 3 | 2020 | 6 | 0.300 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 4 | 2010 | 26 | 0.290 |
Why?
|
| Serotonin | 1 | 2007 | 144 | 0.290 |
Why?
|
| Receptors, Opioid, delta | 2 | 2006 | 37 | 0.270 |
Why?
|
| Microscopy, Electron | 4 | 2010 | 351 | 0.270 |
Why?
|
| Calcium Channels, L-Type | 1 | 2005 | 34 | 0.260 |
Why?
|
| Cholinergic Agents | 2 | 2022 | 12 | 0.260 |
Why?
|
| Neuropil | 1 | 2004 | 6 | 0.240 |
Why?
|
| Receptors, GABA-B | 1 | 2004 | 10 | 0.240 |
Why?
|
| Receptors, GABA-A | 2 | 2006 | 89 | 0.240 |
Why?
|
| Nerve Net | 1 | 2005 | 181 | 0.220 |
Why?
|
| Inhibitory Postsynaptic Potentials | 2 | 2017 | 25 | 0.220 |
Why?
|
| Mice | 5 | 2022 | 8474 | 0.210 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2004 | 282 | 0.210 |
Why?
|
| Reproduction | 1 | 2002 | 48 | 0.210 |
Why?
|
| Macaca | 1 | 2021 | 24 | 0.200 |
Why?
|
| Calcium-Binding Proteins | 1 | 2002 | 114 | 0.200 |
Why?
|
| Receptors, Opioid, mu | 1 | 2002 | 70 | 0.200 |
Why?
|
| Sex Characteristics | 1 | 2002 | 295 | 0.180 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 266 | 0.170 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2010 | 71 | 0.170 |
Why?
|
| Brain | 2 | 2016 | 2176 | 0.170 |
Why?
|
| Neuroanatomy | 2 | 2016 | 14 | 0.160 |
Why?
|
| Synaptic Transmission | 3 | 2022 | 236 | 0.160 |
Why?
|
| Phosphorylation | 1 | 2021 | 1200 | 0.150 |
Why?
|
| Gene Expression | 1 | 2020 | 770 | 0.150 |
Why?
|
| Conotoxins | 1 | 2017 | 1 | 0.150 |
Why?
|
| CD57 Antigens | 1 | 2017 | 3 | 0.150 |
Why?
|
| Acetylgalactosamine | 1 | 2017 | 10 | 0.150 |
Why?
|
| Homeostasis | 2 | 2017 | 291 | 0.150 |
Why?
|
| Antibody Specificity | 1 | 2017 | 98 | 0.150 |
Why?
|
| Prion Proteins | 1 | 2017 | 4 | 0.150 |
Why?
|
| PrPC Proteins | 1 | 2017 | 3 | 0.150 |
Why?
|
| Mice, 129 Strain | 1 | 2017 | 44 | 0.150 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 62 | 0.150 |
Why?
|
| Female | 5 | 2022 | 38074 | 0.140 |
Why?
|
| Retinoid X Receptors | 1 | 2016 | 26 | 0.130 |
Why?
|
| Cell Membrane | 1 | 2017 | 525 | 0.130 |
Why?
|
| Tretinoin | 1 | 2016 | 92 | 0.130 |
Why?
|
| Patch-Clamp Techniques | 2 | 2006 | 204 | 0.130 |
Why?
|
| Retinoids | 1 | 2016 | 122 | 0.120 |
Why?
|
| Cell Count | 2 | 2005 | 248 | 0.120 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 493 | 0.120 |
Why?
|
| 3,3'-Diaminobenzidine | 1 | 2013 | 2 | 0.110 |
Why?
|
| Neural Inhibition | 2 | 2004 | 80 | 0.110 |
Why?
|
| Calbindin 1 | 2 | 2003 | 6 | 0.110 |
Why?
|
| Septal Nuclei | 1 | 2011 | 31 | 0.090 |
Why?
|
| Feedback, Physiological | 1 | 2011 | 38 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2011 | 78 | 0.090 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2011 | 79 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 565 | 0.090 |
Why?
|
| Glutamate Decarboxylase | 1 | 2010 | 18 | 0.090 |
Why?
|
| Neuronal Tract-Tracers | 1 | 2010 | 2 | 0.090 |
Why?
|
| Phytohemagglutinins | 1 | 2010 | 16 | 0.090 |
Why?
|
| Photomicrography | 1 | 2010 | 14 | 0.090 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2010 | 95 | 0.090 |
Why?
|
| Affect | 1 | 2011 | 218 | 0.090 |
Why?
|
| Oxytocin | 1 | 2011 | 124 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2010 | 305 | 0.080 |
Why?
|
| Antibodies | 1 | 2008 | 241 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 127 | 0.070 |
Why?
|
| Synaptic Membranes | 1 | 2007 | 8 | 0.070 |
Why?
|
| Afferent Pathways | 1 | 2006 | 31 | 0.070 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2007 | 87 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2016 | 2689 | 0.070 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 122 | 0.070 |
Why?
|
| Lysine | 1 | 2006 | 96 | 0.070 |
Why?
|
| Anti-Anxiety Agents | 1 | 2006 | 107 | 0.070 |
Why?
|
| Rats, Long-Evans | 2 | 2006 | 203 | 0.070 |
Why?
|
| Benzodiazepines | 1 | 2006 | 130 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2006 | 106 | 0.060 |
Why?
|
| Gap Junctions | 1 | 2005 | 29 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2005 | 282 | 0.060 |
Why?
|
| Biomarkers | 1 | 2011 | 1593 | 0.060 |
Why?
|
| Action Potentials | 1 | 2006 | 223 | 0.060 |
Why?
|
| Histocytochemistry | 1 | 2005 | 149 | 0.060 |
Why?
|
| Membrane Potentials | 1 | 2005 | 200 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2011 | 824 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2004 | 99 | 0.060 |
Why?
|
| Electric Stimulation | 1 | 2005 | 218 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2005 | 396 | 0.060 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 765 | 0.060 |
Why?
|
| Neuronal Plasticity | 1 | 2007 | 274 | 0.060 |
Why?
|
| Receptors, Cholinergic | 1 | 2022 | 30 | 0.050 |
Why?
|
| Receptors, Muscarinic | 1 | 2022 | 44 | 0.050 |
Why?
|
| Globus Pallidus | 1 | 2003 | 64 | 0.050 |
Why?
|
| Neuropeptide Y | 1 | 2002 | 11 | 0.050 |
Why?
|
| Thalamus | 1 | 2022 | 82 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 92 | 0.050 |
Why?
|
| Astrocytes | 1 | 2004 | 270 | 0.050 |
Why?
|
| Receptors, AMPA | 1 | 2002 | 99 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2002 | 337 | 0.050 |
Why?
|
| Corpus Striatum | 1 | 2003 | 279 | 0.050 |
Why?
|
| Humans | 3 | 2016 | 68618 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2017 | 362 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2017 | 346 | 0.030 |
Why?
|
| Arginine Vasopressin | 1 | 2011 | 16 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2011 | 50 | 0.020 |
Why?
|
| Colchicine | 1 | 2011 | 48 | 0.020 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2011 | 24 | 0.020 |
Why?
|
| Diazepam | 1 | 2006 | 23 | 0.020 |
Why?
|
| Maze Learning | 1 | 2006 | 138 | 0.020 |
Why?
|
| Naltrexone | 1 | 2006 | 195 | 0.020 |
Why?
|